The Past, Present, and Future of Cardinal Health 3PL Services and Packaging Solutions

Key Takeaways

• Expanded cold‑chain capacity covers 2 °C–8 °C to deep‑frozen storage
• Introduced reusable shippers and recycling to cut packaging waste
• Seven‑day FDA‑approval‑to‑patient program accelerates drug delivery
• New St. Louis distribution center strengthens national logistics footprint
• Growing Exclusive Pharmaceutical Transportation Network reduces handling steps

Pulse Analysis

Biopharma manufacturers are confronting a perfect storm of supply‑chain pressures. Demand for temperature‑controlled logistics has surged as more therapies require refrigeration or deep‑freeze conditions, while regulators and patients alike demand faster time‑to‑market. At the same time, sustainability has moved from a niche concern to a core requirement, pushing companies to adopt reusable packaging and lower carbon footprints. Cardinal Health’s 3PL Services and Packaging Solutions division has positioned itself at the intersection of these trends, offering an integrated platform that blends cold‑chain expertise with eco‑friendly practices.

The division’s integration of packaging capabilities with third‑party logistics creates a seamless pipeline that can move a newly approved drug from FDA sign‑off to the patient in just seven days. This speed is achieved through coordinated warehousing, order fulfillment, and a dedicated transportation network that minimizes touchpoints. By handling a spectrum of temperature ranges—from standard 2 °C–8 °C to ultra‑low‑temperature storage—Cardinal Health ensures that biologics, vaccines, and cell therapies retain potency throughout transit. The reusable shipper program further reduces waste while maintaining compliance with stringent cold‑chain standards.

Looking ahead, Cardinal Health is expanding its physical footprint with a new distribution center in St. Louis, a strategic hub that shortens delivery lanes across the Midwest. The continued growth of its Exclusive Pharmaceutical Transportation Network (EPTN) promises fewer product handoffs, lower risk of temperature excursions, and improved cost efficiency for manufacturers. As the industry leans more heavily on rapid, reliable, and responsible logistics, providers that can combine speed, temperature control, and sustainability—like Cardinal Health—are likely to capture a larger share of the high‑value biopharma supply‑chain market.